Keathley Landscaping has announced enhanced drainage system installation services designed to address water management challenges affecting residential and commercial properties throughout North Texas ...

Israel reportedly deploys Iron Beam laser defence system to intercept Hezbollah rockets amid regional escalation. Here’s how ...

The family and friends of the teen whose body was found behind a South Wilkes-Barre garage last month have started a petition seeking to “turn tragedy into protection” by creating a ...

The cobot feeder includes a storage and retrieval assembly with a UR force- and power-limited robot pedestal, enclosed steel ...

Full-year 2025 net product revenues of $689 millionSYFOVRE® (pegcetacoplan injection) full year 2025 net product revenue of $587 millionEMPAVELI® (pegcetacoplan) full year 2025 net product revenue of ...

New findings that snakes thrive without the hunger hormone ghrelin suggest future obesity drugs could safely mute hunger at its source, complementing today’s satiety‑boosting therapies.

The UP CM called BrahMos a symbol of India's strategic power. Issuing a strong warning to adversaries, he said that if anyone attempts to challenge India's sovereignty, the country would respond ...

Complement 3 glomerulopathy (C3G) is a rare kidney disease that is also considered an autoimmune disorder. There is no single cure for C3G, but several treatments may slow disease progression, protect ...

There are two types of complement 3 glomerulopathy: dense deposit disease (DDD) and C3 glomerulonephritis (C3GN). DDD often begins earlier in life and may progress more quickly. Both are linked to an ...

The complement system is an innate immune response that leads to increased inflammation. The drug pegcetacoplan—a complement inhibitor—was approved for medical use in the United States in 2021 to ...

Department of Rheumatology, Toronto University, Toronto, ON, Canada. Department of Rheumatology, Toronto University, Toronto, ON, Canada. Department of Internal Medicine, Qatif Central Hospital, Qatif ...

Newcastle researchers have revealed the first treatment to target the underlying cause of a rare kidney condition called "C3G" and prevent the disease progressing. Publishing in The Lancet, the ...